Zobrazeno 1 - 10
of 35
pro vyhledávání: '"T. Shivacheva"'
Autor:
T. Shivacheva
Publikováno v:
Folia Medica, Vol 62, Iss 1, Pp 46-51 (2020)
Introduction: The European League Against Rheumatism updates the recommendations for managing rheumatoid arthritis. Again, it is not specified which DAS28 is there in view (with erythrocyte sedimentation rate or C-reactive protein). Aim: The aim of t
Publikováno v:
Annals of the Rheumatic Diseases. 81:1139.1-1139
BackgroundSingle nucleotide polymorphisms (SNPs) in complement C1q component are found to be linked with systemic lupus erythematosus (SLE), but less is known about their association with the clinical and immunological aspects of the disease.Objectiv
Publikováno v:
Annals of the Rheumatic Diseases. 81:1688.3-1689
BackgroundSince the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the coronavirus disease 2019 (COVID-19) (1), our understanding of the underlying pathophysiology is constantly evolving in order to expl
Publikováno v:
Annals of the Rheumatic Diseases. 81:813.1-813
BackgroundThe concept of axial spondyloarthritis (axSpA) and non-radiographic axSpA (nr-axSpA), a subgroup of axSpA, has recently emerged. There are several studies proving the similar levels in disease activity and quality of life in patients with o
Autor:
T. Georgiev, R. Moraliyska, S. Bogdanova-Petrova, G. Gerganov, P. Kabakchieva, S. Dimitrov, S. Hristova, T. Shivacheva
Publikováno v:
Annals of the Rheumatic Diseases. 81:1697.3-1698
BackgroundBulgaria is among the countries with the lowest vaccination rate of adult population in Europe. The presence of autoimmune rheumatic disease could further contribute to vaccine hesitancy and skepticism and influence patients’ attitudes to
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S. Hristova, S. Dimitrov, Tsvetoslav Georgiev, T. Shivacheva, G. Gerganov, S. Bogdanova-Petrova
Publikováno v:
Annals of the Rheumatic Diseases. 80:1138.1-1138
Background:Sustainability, the ability of drugs to maintain remission or low disease activity (LDA) in patients with rheumatoid arthritis (RA), plays a crucial role for the prevention of structural damage to joints and thus, preserving patients’ fu
POS1224 RHEUMATIC MANIFESTATIONS IN COVID-19 PATIENTS - SINGLE-CENTER EXPERIENCE AMIDST THE PANDEMIC
Autor:
T. Shivacheva, Tsvetoslav Georgiev, S. Hristova, G. Gerganov, S. Bogdanova-Petrova, S. Dimitrov
Publikováno v:
Annals of the Rheumatic Diseases. 80:896.1-896
Background:Recently evolved from a monochromic flu-like disease to a polysyndromic “spectrum of disease”, our understanding of coronavirus disease 2019 (COVID-19) is still far from being complete [1]. Hyperinflammation involving not only the lung
Publikováno v:
Annals of the Rheumatic Diseases. 79:1738.2-1739
Background:Osteoarthritis (OA) is a leading cause of disability worldwide and pain is its cardinal symptom. Ranging from structural injuries to central sensitization, multifactorial mechanisms play an important role in pain perception in patients wit
Publikováno v:
Annals of the Rheumatic Diseases. 79:1484.2-1485
Background:Systemic lupus erythematosus (SLE) is autoimmune connective tissue disorder of unclear etiology. It is characterized by autoantibody production and a variety of clinical manifestations. The introduction of biological treatment over the pas